Arsenical Keratosis – Causes, Symptoms, Treatment

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

On this page6 sections

Article Summary

Arsenical keratosis is a precancerous dermatosis seen in patients with chronic arsenic toxicity (CAT).[1] It is characterized by corn-like, yellowish, hyperkeratotic papules and plaques, primarily affecting the palms and soles. Often it starts as small areas of hyperkeratosis, which increase in number and size to involve the entire palms and soles. Rarely, it can spread to the dorsa of the hands and feet, other parts of...

Key Takeaways

  • This article explains Causes of Arsenical Keratosis in simple medical language.
  • This article explains Pathophysiology in simple medical language.
  • This article explains Diagnosis of Arsenical Keratosis in simple medical language.
  • This article explains Treatment of Arsenical Keratosis in simple medical language.
Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.
Choose your reading view

Patient View highlights a simple learning journey. Clinical View reveals structure, evidence, and editorial completeness.

Definition

Arsenical keratosis is a precancerous dermatosis seen in patients with arsenic toxicity (CAT). It is characterized by corn-like, yellowish, hyperkeratotic papules and plaques, primarily affecting the palms and soles. Often it starts as small areas of hyperkeratosis, which increase in number and size to involve the entire palms and soles. Rarely, it can spread to the dorsa of the hands and feet, other parts of the body, and may progress to squamous cell .

Arsenical keratosis with skin hyperpigmentation is the earliest and most common presenting complaint in CAT. Therefore, it plays a crucial role in guiding clinicians towards the early and treatment of CAT. Apart from conditions like skin hyperpigmentation and Mees’ lines in nails, arsenical keratosis can sometimes coexist with single or multiple lesions of Bowen’s disease, basal cell carcinoma, and squamous cell carcinoma. Identification and elimination of the source of arsenic exposure are of utmost importance, as these patients are at high risk of developing multisystem disorders and visceral malignancies.

Causes of Arsenical Keratosis

Arsenical keratosis is a cutaneous manifestation of ‘arsenicosis,’ defined by the World Health Organization (WHO) as a chronic health condition resulting from the ingestion of arsenic above the safe limit for a minimum duration of 6 months. The time taken for skin lesions to appear depends on the physical and chemical form of arsenic, the route, dose, duration, frequency of exposure, and can vary from anywhere between 4 years to 40 years. Inorganic arsenic is a ubiquitous element that has been identified as a class I human carcinogen by the International Agency for Research on Cancer. Some of the well-recognized and documented sources of arsenic exposure are as follows:

  • Contaminated groundwater- Used for drinking, cooking, and irrigating crops.
  • Food crops- Crops that are grown in contaminated soil or irrigated with contaminated water can be a source of arsenic. Whole-grain rice is known to have higher arsenic content than polished rice.
  • Medications- Fowler’s solution (1% potassium arsenite) was used in the 20th century to treat various dermatoses and . In the early 1900s, until the advent of penicillin, arsenic-containing drugs salvarsan and neo-salvarsan were used in the treatment of syphilis. At present, the only for medicinal arsenic, which is approved by the Food and Drug Administration (FDA), is the treatment of relapsed or promyelocytic . Arsenic also continues to be an important component of some of the Chinese herbal medicines and ayurvedic medicines.
  • Occupational exposure- Arsenic is used in the manufacture of alloys and in the processing of pigments, textiles, glass, paper, hide (tanning process), wood preservatives, and ammunitions. Workers involved in smelting and mining of metals have greater exposure to arsenic than those involved in the manufacture of insecticides/ pesticides/ herbicides, pharmaceuticals, and poultry feeds. The population living close to these industries or mining activities is also at risk.
  • Tobacco- Tobacco plants can take up arsenic naturally present in contaminated soil and insecticides. Cigarettes manufactured in the 1950s had high arsenic content, which has been gradually reduced to acceptable levels over the years. However, regulating the arsenic content in handmade cigarettes like bidis has not yet been possible.

Pathophysiology

Though the exact pathomechanism underlying the premalignant and manifestations of chronic arsenic exposure is unknown, there are several hypotheses that have been proposed and researched in several parts of the world. Arsenic metabolism in the body has a key role in most of these theories. Some such tested theories are as follows:

  • polymorphism of enzymes involved in the metabolic pathway; arsenite methyltransferase (AS3MT) is the main mediator in the biomethylation of arsenic.
  • Global DNA hypomethylation due to depletion of S-adenosylmethionine in cells during the process of arsenic biomethylation. This leads to aberrant gene expression in cells, resulting in carcinogenesis.
  • Reactive oxygen species generated during the metabolism of arsenic causes oxidative DNA damage, resulting in chromosomal abnormalities and sister chromatic exchange.

The development of premalignant and malignant lesions is further facilitated by an individual’s genetic susceptibility. This includes polymorphism in the DNA repair pathway genes (e.g., ERCC2, XRCC3), (TP53), glutathione S-transferase superfamily enzymes, IL10, TNF alpha, and NLRP2. Studies have demonstrated an exaggerated expression of pro-inflammatory cytokines in chronic arsenic toxicity. Recent studies have revealed the role of arsenic-induced epigenetic alterations i.e., changes in gene expression in the development of premalignant dermatoses and malignancy. Thus, a complex interaction of toxicodynamics of arsenic with an individual’s genetics leads to aberrations in cellular proliferation and differentiation, resulting in unregulated cell growth seen in arsenical keratosis and other tumors.

Diagnosis of Arsenical Keratosis

Prominent compact hyperkeratosis, parakeratosis, and acanthosis are the constant features found on histopathological examination of arsenical keratosis. Papillomatosis and vacuolated keratinocytes may be present. Keratinocyte atypia may or may not be seen, and its severity can vary from atypia to features of squamous cell carcinoma in situ, which is indistinguishable from Bowen’s disease. None of these histopathological features are specific for arsenical keratosis. Although does not confirm the diagnosis of arsenical keratosis, it is useful in detecting malignant transformation.

A similar histopathological picture can be seen in actinic keratosis, Bowen’s disease, and verruca vulgaris.

Toxicokinetics

Arsenic, a metalloid, naturally occurring in sediments and minerals, is a colorless, odorless, and tasteless chemical carcinogen. The inorganic forms of arsenic, especially arsenite (trivalent state) was found to be more toxic to humans than the organic form present in seafood like fish and crustaceans. Hence, the chances of toxicity due to seafood consumption are negligible.

Arsenic enters the bloodstream predominantly through gastrointestinal absorption. Entry through the respiratory route and transcutaneous absorption is also known to occur. A small portion of the absorbed arsenic gets excreted unchanged in the urine. The major portion undergoes hepatic biomethylation to monomethylarsonic acid and dimethyl arsenic acid and gets excreted in the urine. Thus there is rapid elimination of arsenic from the bloodstream. But with chronic exposure to arsenic, it accumulates preferentially in , , lung, gastrointestinal tract, skin, and muscle. This can be explained by the high affinity of arsenic for sulfhydryl group-containing proteins and enzymes present in these organs.

Most of the accumulated arsenic gets excreted over time; however, keratin-rich tissue like nails, hair, and skin are an exception to this.

History and Physical

The usual presenting complaints are horny lesions over the extremities, particularly involving the palms and soles, which may be associated with and/or fissuring. The lesions are insidious in and gradually increase in number and size. On physical examination, multiple yellowish to pigmented hyperkeratotic papules and plaques that start over the pressure points over soles and palms are seen. As the disease progresses, the lesions increase in number, size, and thickness and can coalesce to form large verrucous plaques. There can be diffuse involvement of palms and soles and can spread to the dorsa of hands, feet, and the rest of the body. Based on the thickness and size of the lesions, arsenical keratosis can be graded as follows:

  • Mild- Slight thickening of skin or papules of size less than 2 mm on a background skin with grit-like texture, best appreciated by palpation.
  • - Multiple raised, warty, keratotic, corn-like papules of size 2-5 mm.
  • - Keratotic papules of size more than 5mm or confluent keratotic plaques, with or without fissures.

Arsenical keratosis is often accompanied by pigmentary disturbances, which can be / diffuse hyperpigmentation or patchy hyperpigmentation predominantly involving the skin folds. Two striking patterns of pigmentation are seen in CAT; symmetrically distributed hyperpigmented macules over trunk and extremities described as ‘raindrop’ pattern, and guttate hypopigmentation on a background of hyperpigmentation described as ‘raindrop on a dusty road’ pattern. Oral mucosal pigmentation has also been described. Aldrich-Mees lines are single or multiple transverse white bands traversing the full width of the nail and involve the fingernails and toenails of patients. Additionally, these patients may develop single or multiple lesions of Bowen’s disease, squamous cell carcinoma, and basal cell carcinoma over normal skin of both exposed and covered sites.

CAT is a multisystem disorder, and patients with arsenical keratosis can have symptoms of chronic liver disease, chronic lung disease, distal sensorimotor , , ischemic heart disease, , and non-specific gastrointestinal symptoms like anorexia, , and . They may also complain of , weakness, fatigue, redness of eyes (conjunctival congestion), and swelling of legs (non-pitting pedal edema). Diabetes and hypertension are prevalent in these patients.

Thus, while evaluating a patient from an arsenic-endemic area, presenting with acquired palmoplantar keratoderma, arsenical keratosis should be suspected, and the clinician must look for other skin manifestations and systemic symptoms of CAT. This should be followed by appropriate laboratory investigations to confirm the diagnosis. Arsenical keratosis usually manifests after years of arsenic exposure; therefore, a thorough history which includes past, personal, medical, drug, and occupational details are required to identify the source of arsenic exposure. The history of similar skin or systemic complaints in other members of the family, neighborhood, and workplace points to an environmental toxin like arsenic being the cause.

Evaluation

Investigations should be directed towards establishing CAT in the patient and identifying the source of arsenic exposure.

  • Estimation of arsenic concentration in drinking water/well water- An acid-washed plastic container is used to collect at least 50ml of water to be tested. WHO has set a provisional guideline value of 10 mcg/L for the maximum permissible concentration of arsenic in drinking water. However, countries like India and Bangladesh follow the old guidelines and have a higher cut off value of 50 mcg/L.
  • Estimation of arsenic concentration in urine- It is an indicator of recent exposure to arsenic and should be ideally done in a 24-hour urine collection. An easier alternative is to test a spot urine sample or the first-morning urine sample. Both methods are comparable as the arsenic excreted remains stable throughout the day. Seafood containing the non-toxic organic form of arsenic should be avoided for at least four days prior to testing, as it can make the results unreliable. A concentration of more than 50 mcg/L proves recent exposure to arsenic.
  • Estimation of arsenic concentration in hairs and nails- After using arsenic-free shampoo to wash hair and ensuring that the patient has not used any coloring agent, 30 hairs of 6 cm length from females and 60 hairs with the base from males are collected and tested. Nail clippings are taken from all fingernails and toenails. A concentration of arsenic more than 1 mg/kg of dry hair and more than 1.5 mg/kg of the nail indicates arsenic exposure in the preceding 9 months.
  • Estimation of arsenic concentration in suspected sources like medications or pesticides by using atomic absorption spectrometry, calorimetric method, spectrophotometry, etc.
  • Histopathological examination of the keratotic skin lesions is done to look for malignant transformation but has little role in the conformation of the diagnosis.

Estimation of arsenic concentration in drinking water is usually the first step in the evaluation of CAT. However, in clinical scenarios where drinking water data is unreliable, like in the case of a migratory population, the patient’s biological sample analysis is crucial in establishing the diagnosis.

Treatment of Arsenical Keratosis

After establishing arsenic toxicity in the patient, and positively identifying the source of arsenic exposure, prevention of further exposure forms the mainstay of treatment. Mild to moderate disease have shown improvement in many such instances. Smoking and nutritional deficiencies are predisposing factors for this premalignant condition; therefore, patients should be advised to stop smoking and consume a well-balanced high protein diet. Supplementation of antioxidants like vitamins A, C, E is also believed to prevent cancer.

Treatment of arsenical keratosis is not mandatory, and the objective is to administer a supportive and symptomatic treatment that relieves the patient’s discomfort. There are no universally accepted standard guidelines for the treatment of arsenical keratosis. Treatment should be tailored to the patient’s needs, the severity of the disease, comorbidities, and tolerance for pain. Treatment options that have been tried over the years are as follows:

  • Cryotherapy
  • Curettage and electrodessication
  • Carbon dioxide laser ablation
  • Topical keratolytic agents- salicylic acid (5 to 10%), urea (10 to 20%)
  • Imiquimod 5% cream
  • Topical 5-fluorouracil
  • Oral retinoids
  • Surgical excision

Acitretin with topical keratolytic agents can be used to treat patients with extensive lesions. It can play the role of chemoprevention in CAT associated cancers. Patients should be instructed to apply imiquimod cream once daily for 6 weeks or 3-5 times per week for 8 weeks. Biannual clinic visits, annual chest radiographs, and selective tests based on symptoms are of utmost importance for early detection of cutaneous and visceral malignancies.

Differential Diagnosis

  • Verruca vulgaris
  • Corns/ calluses
  • Dermatophyte infection
  • Lichen planus
  • Hyperkeratotic eczema
  • Palmoplantar psoriasis
  • Porokeratosis punctata palmaris et plantaris
  • Clavi syphilitici
  • Inherited palmoplantar keratoderma

Complications

  • In extreme cases of arsenical keratosis, diffuse involvement of palms and soles with painful fissuring can be seen. This can be debilitating for the patient, affecting their daily activities, and in turn, their quality of life.
  • Arsenical keratosis is one of the several skin conditions that can be associated with a cutaneous horn.
  • Malignant transformation, usually, SCC should be suspected when there is a sudden increase in size, induration, fissuring, bleeding, inflammation, perilesional erythema, and ulceration.
  • Several organ systems can be affected in CAT, some leading to irreversible changes, chronic disease, and also predisposing to visceral malignancies.
RX Clinical Pathway Engine

Continue through a complete learning pathway

Move from understanding the topic to symptoms, tests, treatment, medicines, monitoring, and prevention.

Search the complete library
  1. Understand the condition Begin with the essential facts and a clear explanation of the topic.
  2. Recognize symptoms Learn common symptoms, signs, and patterns of presentation.
  3. Know when to seek help Review urgent warning signs and when professional assessment may be needed.
  4. Understand causes and risks Explore causes, risk factors, mechanisms, and contributing conditions.
  5. Explore tests and diagnosis Learn how clinicians assess the condition and which investigations may be discussed.
  6. Learn treatment approaches Review general treatment categories and management principles.
  7. Understand medicines safely Continue to medicine education, uses, precautions, and monitoring.
  8. Plan monitoring and follow-up Understand monitoring, complications, rehabilitation, and follow-up learning.
  9. Review prevention and self-care Explore prevention, healthy routines, and questions to discuss with a clinician.

Conditions & Diseases

Background, symptoms, causes, diagnosis, and care.

Explore this library

Tests & Investigations

Laboratory, imaging, screening, and diagnostic education.

No strong indexed relationship is available yet.

Explore this library

Medicines

Uses, safety, monitoring, and related medicine knowledge.

No strong indexed relationship is available yet.

Explore this library
Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Arsenical Keratosis – Causes, Symptoms, Treatment

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

Internal learning pathway

Explore related RX articles

Related guides from RX Harun are grouped to help readers move from overview to symptoms, tests, treatment, and safe next steps.

Health (A - Z)
  1. Benign Familial Nocturnal Alternating Hemiplegia of Childhood (BNAHC) DefinitionBenign? familial nocturnal alternating hemiplegia of childhood (BNAHC) is a very rare childhood condition in which…
  2. Benign Adult Familial Myoclonic Epilepsy (BAFME DefinitionBenign? adult familial myoclonic epilepsy? (BAFME) is a rare, inherited? brain condition. It usually starts in…
  3. Polyglandular Autoimmune Syndrome Type 1 (APS-1) DefinitionPolyglandular autoimmune? syndrome? type 1 (APS-1)—also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)—is a rare, inherited? immune-system…
  4. Tripeptidyl-Peptidase II (TPP2) Deficiency DefinitionTripeptidyl-Peptidase II (TPP2) deficiency is a rare, inherited? condition where the TPP2 gene does not work…
  5. Painful Bruising Syndrome DefinitionPainful bruising? syndrome? is a very rare condition where tender, burning or stinging skin patches suddenly…
  6. Autoerythrocyte Sensitization Syndrome DefinitionAutoerythrocyte Sensitization Syndrome? is a rare condition where people develop painful, tender skin swellings that turn…